+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Ilexgenin A

BP1759
108524-94-3
98%
Biopurify
Ilex pubescens
Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth. It has anti-atherosclerotic activity, it shows reduction of atherosclerosis in apolipoprotein E deficient mice. Ilexgenin A is useful in the management of cardiovascular diseases in obesity, it inhibits endoplasmic reticulum stress and ameliorates endothelial dysfunction via suppression of TXNIP/NLRP3 inflammasome activation in an AMPK dependent manner. Ilexgenin A could be regarded as a promising agent for the treatment of melanoma, it exerts anti-melanoma activity by arresting the cell cycle at G0/G1 and regulating IL-6 and TNF-α production.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1759-5mg 5mg
BP1759-10mg 10mg
BP1759-20mg 20mg
BP1759-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Product drug property prediction parameters

  • 115.0600

  • 4.1780

  • 1.0594

  • .0191

  • 3.1576

  • 6.5664

  • Low

  • 89.7982

  • 5.0305

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • No

Ilexgenin A Reference LiteratureMORE+